Aidoc Announces Series B Extension to $47M As Market Demand for Proven Radiology AI Soars

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

September 16, 2020

Aidoc today announced it has raised an additional $20 million as part of its Series B extension round which brings the total amount of funding raised by the company to $60 million to date.

The announcement comes as radiology practices continue to choose Aidoc as their core AI solution, tripling the company’s revenue since the beginning of 2020, even amidst a global pandemic.

“We are incredibly proud and excited to be able to continue to back the Aidoc team,” said Dan Krasnostein, Partner at Square Peg Capital. “The value AI brings in supporting radiologists is so obvious to us and Aidoc has stamped itself as a clear leader in the space. Since our first investment the company has continued to make giant steps forward with new products brought to market and a significant increase in the number of customers they serve. Supporting a business that is improving patient care and saving lives on a daily basis is incredibly exciting.”

Aidoc’s comprehensive suite of AI solutions for radiology includes six FDA-cleared products for flagging acute abnormalities directly in the radiology workflow. The company has undergone a rapid global expansion, now serving more than 400 health centers in five continents. On a recent KLAS webinar, Aidoc’s partners shared their satisfaction from the value they have experienced in turnaround time as well as the ease of deployment within their clinical environment.

“I am encouraged to see that recent changes in the healthcare world helped crystalize the value of AI,” said Aidoc co-founder and CEO Elad Walach. “As healthcare organizations work through case backlogs and prepare for a different future – solutions that can show improved operational efficiency and increased revenue potential are being prioritized. Our solutions have augmented radiologists to provide the highest standard of care, reducing turnaround time, and helping save lives for over 3 years now and this funding allows us to continue expanding our comprehensive portfolio as well as facilitate our rapid expansion into additional practices across the globe.”



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.